Reminder…Herbicide Field Day on Wedelia & Sedges
This Friday, April 4, 2008
To: Landscape & Golf Course Industries
Wedelia is often used as a groundcover. However, some people consider it a weed and efforts are currently being taken to place it on the invasive weed list. Recently an herbicide trial was conducted with Sedge-Hammer (SledgeHammer | Sledge-Hammer), Manage, Certainty, Monument, and Image for the control of wedelia, purple nutsedge, green kyllinga, and white kyllinga. You are invited to attend a field day to observe the herbicide effects on wedelia and the early results on these sedges.
Date: April 4, 2008 (Friday)
Place: Meet at Maui Community College Greenhouse, Kahului
Time: 11:00 to 12:00 pm
Registration Deadline April 3.
To register you may call the Cooperative Extension Service at 244-3242 x222 or x230.
Please notify us if you require special assistance or if you need directions to attend this event.
- One (1) pesticide credit from the Hawaii Dept. of Agriculture will be provided for categories 3 (Ornamental & Turf) and 10 (Demonstration, Research & Instruction).
- Golf Course Superintendents Association of America educational credits will also be awarded.
- One (1) UH/CES Landscape Advisor IPM credits will be provided.
This project is supported in part by the County of Maui.
Norman M. Nagata
Extension Agent (Landscape, Turfgrass, Ornamental Plant)
University of Hawaii at Manoa, Cooperative Extension Service
310 Kaahumanu Avenue, Bld. 214; Kahului, Maui, Hawaii 96732
Tele. (808)244-3242 x 230, Fax (808)244-7089
Translation to English by Lindenmaier M and Brinckmann J
31. December 2001
Analysis of hepatotoxic reactions listed by the BfArM (German Federal Institute for Drugs and Medical Devices)
From the original 32 suspected cases, there are only 4 cases with probable causality to kava that remain after substraction of the double entries, the cases unrelated to kava as well as the improbable or doubtful ones. Of these 4 cases, only one is related to a monograph-conforming dosage regimen (Strahl et al. 1998). The remaining 3 cases should be therefore classified as usages associated with overdosages. In the only kava side effect case associated with recommended use and a somewhat causal certainty, there seems to be an existing relationship to an immunoligical condition in combination with a congentical cytochrom P450-2D6 deficency. A comparable cause could also possibly be related to one case associated with overdosage (IKS-Nr. 2000-0014; see below).
Read Complete Article Here